SomnoMed Limited
SOMNF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,456 | -$12,242 | -$7,867 | -$4,426 |
| Dep. & Amort. | $5,741 | $6,805 | $5,117 | $3,936 |
| Deferred Tax | $0 | $0 | -$13,494 | -$7,947 |
| Stock-Based Comp. | $1,947 | $77 | $1,035 | $1,190 |
| Change in WC | -$4,231 | -$3,285 | -$3,144 | $1,906 |
| Other Non-Cash | $7,784 | $2,312 | $14,472 | $7,199 |
| Operating Cash Flow | $7,784 | -$6,333 | -$3,880 | $1,858 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,421 | -$1,387 | -$6,415 | -$8,788 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $317 |
| Other Inv. Act. | -$1,556 | -$3,954 | $0 | $0 |
| Investing Cash Flow | -$3,977 | -$5,341 | -$6,415 | -$8,472 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,340 | -$16,789 | $6,608 | $2,078 |
| Stock Issued | $0 | $38,078 | $0 | $0 |
| Stock Repurch. | $0 | -$2,074 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$44 | -$2,537 | $0 | $15 |
| Financing Cash Flow | -$3,385 | $16,678 | $6,608 | $2,092 |
| Forex Effect | $693 | -$782 | -$1 | -$944 |
| Net Chg. in Cash | $1,115 | $4,222 | -$3,688 | -$5,466 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $16,179 | $11,956 | $15,644 | $21,110 |
| End Cash | $17,293 | $16,179 | $11,956 | $15,644 |
| Free Cash Flow | $5,363 | -$7,720 | -$10,295 | -$6,931 |